The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCyanconnode Regulatory News (CYAN)

Share Price Information for Cyanconnode (CYAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.30
Bid: 8.20
Ask: 8.40
Change: 0.00 (0.00%)
Spread: 0.20 (2.439%)
Open: 8.30
High: 8.30
Low: 8.30
Prev. Close: 8.30
CYAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

17 Mar 2016 07:00

RNS Number : 3634S
Cyan Holdings Plc
17 March 2016
 

Cyan Holdings plc

("Cyan" or "the Company")

 

Issue of Equity

 

Cyan (AIM: CYAN.L), the integrated system and software design company delivering mesh based flexible wireless solutions for utility metering and lighting control, is pleased to announce that it has raised £450,000 by way of a subscription for 250,000,000 ordinary shares of 0.01p each ("Subscription Shares") at a price of 0.18 pence per share (the "Issue Price") (the "Subscription"), representing a premium of 20 per cent. to the closing mid-market share price on 16 March 2016.

 

Highlights

 

· Issue of 250,000,000 Subscription Shares subscribed by new and existing private investors to raise proceeds of £450,000

· The Issue Price represents a premium of 20 per cent. to the closing mid-market price of 0.15 pence on 16 March 2016, being the latest dealing day prior to the announcement of the Subscription

· The proceeds of the Subscription will be used for working capital purposes

· The Subscription is not underwritten. The Subscription is conditional only upon admission of the Subscription Shares to trading on AIM

 

The Subscription has been undertaken pursuant to the general authorities granted to the board of directors at the general meeting of the Company held on 30 June 2015 and therefore no further shareholder approval is required. The Company has received HMRC confirmation that the Subscription Shares will qualify for EIS tax relief under the Company's existing EIS headroom of up to £12.6M (of which £3.9M is available in the 12 month period to June 2016, and £535k still available at the Issue Price under the general authorities granted to the board of directors in June 2015).

 

Following the admission of the new Ordinary Shares, the Company's total issued share capital will be 7,080,506,012 ordinary shares of 0.01 pence each. This figure of 7,080,506,012 may be used by shareholders as the denominator by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

 

Application will be made for the admission of the Subscription Shares to trading on AIM and it is expected that the Subscription Shares will be admitted to trading on AIM at 8.00 a.m. on 23 March 2016. The Subscription Shares will rank pari passu in all respects with the Company's existing ordinary shares of 0.01 pence each.

 

John Cronin, Executive Chairman of Cyan, commented:

 

"I was delighted to be approached by new investors wishing to take advantage of the EIS tax relief available through investments in Cyan during the tax year ending on 5th April 2016. I was particularly pleased that we were able to secure these investments at a premium to the current share price. I'd like to welcome our new shareholders and thank the existing shareholders for their continued support."

 

 

Enquiries:

 

 

Cyan Holdings plc

Tel: +44 (0) 1954 234 400

John Cronin, Executive Chairman

 

Cantor Fitzgerald Europe (Nomad and Broker)

Tel: +44 (0) 20 7894 7000

 

Andrew Craig / Richard Salmond / Chris Viggor

 

Beaufort Securities Limited (Broker)

Jon Belliss

 

 

 

Tel: +44 (0) 20 7382 8300

 

Walbrook PR (Investor Relations)

Tel: +44(0) 20 7933 8780

Paul Cornelius / Nick Rome

cyan@walbrookpr.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEAKADDCBKDQND
Date   Source Headline
18th Apr 20247:00 amRNSAppointment of Joint Broker
17th Apr 20241:56 pmRNSHolding(s) in Company
16th Apr 20247:00 amRNSTrading Update
15th Apr 20247:00 amRNSOrder For A New Deployment In India
12th Apr 20247:00 amRNSMiddle East Energy Leadership Summit 2024
15th Jan 20247:00 amRNSAppointment of Non-Executive Director
11th Jan 20247:00 amRNSOrder For One Million Omnimesh Modules
27th Dec 20234:18 pmRNSDirector Dealing
19th Dec 20237:00 amRNSInterim Results
6th Dec 20231:32 pmRNSChange of Registered Office
1st Dec 20234:18 pmRNSHolding(s) in Company
21st Nov 20232:31 pmRNSHolding(s) in Company
20th Nov 20236:14 pmRNSIssue of Share Options – Correction
20th Nov 20237:00 amRNSNamed as One of the Fastest Growing Companies
17th Nov 20233:45 pmRNSDirector Option Grants
17th Nov 20238:30 amRNSHolding(s) in Company
16th Nov 202312:48 pmRNSHolding(s) in Company
15th Nov 20237:00 amRNSRanked 2nd Fastest-Growing UK Company in India
13th Nov 20236:11 pmRNSPlacing and Subscription – update
9th Nov 20238:02 amRNSResult of Oversubscribed Placing and Subscription
8th Nov 20235:24 pmRNSProposed Placing and Subscription to Raise c.£2.5m
31st Oct 20237:15 amRNSContract in the Middle East and North Africa
10th Oct 20237:00 amRNSOrder for 300,000 Omnimesh Modules
5th Oct 20237:00 amRNSTrading Update
24th Aug 202312:18 pmRNSResult of AGM
17th Aug 20231:00 pmRNSHolding(s) in Company
15th Aug 20237:00 amRNS2023 Annual General Meeting
4th Aug 20235:34 pmRNSDirector Dealing
2nd Aug 20237:00 amRNSOrder for 300,000 Omnimesh Modules
26th Jul 20235:34 pmRNSCorrection: Final Results
26th Jul 20237:00 amRNSFinal Results
25th Jul 20237:00 amRNSNotice of Results & Investor Presentation
6th Jul 20237:00 amRNSTrading Update
22nd Jun 20237:00 amRNSCyanConnode India is a Start-Up 50 Trailblazer
25th May 20238:10 amRNSOrder for 600,000 Omnimesh Modules
9th May 20233:45 pmRNSHolding(s) in Company
17th Apr 20237:00 amRNSInterview with MD & CEO for CyanConnode India
3rd Apr 20237:00 amRNSCyanConnode and Alfanar Sign MOU for AMI projects
21st Mar 20237:15 amRNSHardman Research - Acceleration and revenue uplift
13th Mar 20237:00 amRNSCyanConnode Banking Arrangements
7th Mar 20237:00 amRNSCollaboration with Silicon Laboratories
6th Mar 20237:00 amRNSAppointment of Nominated and Financial Adviser
6th Feb 20238:51 amRNSStrategic Framework Agreement - Replacement
6th Feb 20238:21 amRNSStrategic Framework Agreement
6th Feb 20237:00 amRNSStrategic Framework Agreement
31st Jan 20237:00 amRNSHolding(s) in Company
24th Jan 20238:00 amRNSResult of Oversubscribed Placing and Subscription
23rd Jan 20235:11 pmRNSProposed Placing and Subscription
19th Jan 20237:00 amRNSChange of Adviser
4th Jan 20237:00 amRNSOrder From New Partner

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.